A detailed history of Bank Of New Hampshire transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bank Of New Hampshire holds 23,802 shares of MRK stock, worth $2.34 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares
23,802
Previous 23,484 1.35%
Holding current value
$2.34 Million
Previous $2.91 Million 7.05%
% of portfolio
0.68%
Previous 0.76%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$111.15 - $128.97 $35,345 - $41,012
318 Added 1.35%
23,802 $2.7 Million
Q2 2024

Jul 01, 2024

BUY
$123.8 - $132.96 $48,653 - $52,253
393 Added 1.7%
23,484 $2.91 Million
Q1 2024

Apr 10, 2024

BUY
$113.24 - $131.95 $78,588 - $91,573
694 Added 3.1%
23,091 $3.05 Million
Q4 2023

Feb 02, 2024

SELL
$100.18 - $109.02 $75,335 - $81,983
-752 Reduced 3.25%
22,397 $2.44 Million
Q3 2023

Oct 10, 2023

BUY
$102.95 - $114.33 $43,753 - $48,590
425 Added 1.87%
23,149 $2.38 Million
Q2 2023

Jul 28, 2023

BUY
$108.61 - $118.38 $151,402 - $165,021
1,394 Added 6.54%
22,724 $2.62 Million
Q1 2023

Apr 04, 2023

BUY
$102.94 - $114.86 $77,616 - $86,604
754 Added 3.66%
21,330 $2.27 Million
Q4 2022

Jan 10, 2023

BUY
$87.44 - $112.11 $183,973 - $235,879
2,104 Added 11.39%
20,576 $2.28 Million
Q3 2022

Oct 24, 2022

BUY
$84.53 - $94.96 $104,563 - $117,465
1,237 Added 7.18%
18,472 $1.59 Million
Q2 2022

Jul 08, 2022

BUY
$83.49 - $94.64 $581,591 - $659,262
6,966 Added 67.84%
17,235 $1.57 Million
Q1 2022

Apr 20, 2022

SELL
$73.51 - $82.4 $8,012 - $8,981
-109 Reduced 1.05%
10,269 $843,000
Q4 2021

Jan 12, 2022

BUY
$72.28 - $90.54 $184,603 - $231,239
2,554 Added 32.64%
10,378 $795,000
Q2 2021

Jul 06, 2021

BUY
$70.31 - $77.77 $550,105 - $608,472
7,824 New
7,824 $609,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $249B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Bank Of New Hampshire Portfolio

Follow Bank Of New Hampshire and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New Hampshire, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New Hampshire with notifications on news.